KCa3.1 INHIBITORS FOR PODOCYTE PROTECTION
US-2024391880-A1 · Nov 28, 2024 · US
US9440935B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9440935-B2 |
| Application number | US-201414901155-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 25, 2014 |
| Priority date | Jun 27, 2013 |
| Publication date | Sep 13, 2016 |
| Grant date | Sep 13, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a novel method for producing 2-phenyl-1,3-benzoxazoles of formula (I).
Opening claim text (preview).
The invention claimed is: 1. Process for producing 2-phenyl-1,3-benzoxazoles of formula (I), wherein R 1 is hydrogen, C 1 -C 6 -alkyl, halogen, OH or OR 2 ; and R 2 is C 1 -C 6 -alkyl, propargyl or allyl, said process comprising the steps of (i) reacting 2-aminophenol (II) with a benzoyl chloride of formula (III) to the amide of formula (IV) 10 followed by (ii) cyclisation of the amide (IV) to 2-phenyl-1,3-benzoxazol of formula (I), wherein step (i) is carried out in an inert organic solvent in the presence of at least 0.75 mole-equivalent of sodium hydrogen carbonate or potassium hydrogen carbonate based on the benzoyl chloride of formula (III). 2. A process according to claim 1 , wherein R 1 denotes to a linear C 1 -C 4 -alkyl radical, to OR 2 wherein R 2 is a propargyl or an allyl radical, or to a fluor radical. 3. A process according to claim 2 , wherein R 1 is a fluor radical. 4. A process according to claim 1 , wherein the inert solvent is selected from the group consisting of toluene, xylene, dioxane, tetrahydrofuran or 2-methyl-tetrahydrofurane. 5. A process according to claim 1 , wherein the inert solvent is 2-methyltetrahydrofuran. 6. A process according to claim 1 , wherein the amount of the inert solvent is selected such that the amount of the benzoyl chloride of formula (III) is in the range of 0.001-2 g/ml solvent, preferably in the range of 0.01-1 g/ml solvent, most preferably in the range of 0.1-0.5 g/ml. 7. A process according to claim 1 , wherein the amount of sodium or potassium hydrogen carbonate is selected in the range of 0.75-1.5 mole-equivalents based on the amount of the benzoyl chloride of formula (III). 8. A process according to claim 1 , wherein sodium hydrogen carbonate is used. 9. A process according to claim 1 , wherein the molar ratio of aminophenol (II) to benzoylchloride (III) is selected in the range of 0.75-1.25, such as more preferably in the range of 0.9-1.1. 10. A process according to claim 1 , wherein the amide (IV) is isolated before the cyclisation step. 11. A process according to claim 1 , wherein the cyclization is carried out in toluene or xylene in the presence of an acidic catalyst selected from the group consisting of methanesulfonic acid and/or p-toluenesulfonic acid. 12. A process according to claim 11 , wherein the reaction water formed during the cyclization is removed by azeotrop distillation. 13. A process according to claim 1 , wherein the process comprises after the cyclization step (ii) an additional decolorization step. 14. A process according to claim 13 , wherein the decolorization is done by treatment with activated charcoal.
Aryl or substituted aryl radicals · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.